[go: up one dir, main page]

PH23436A - 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions - Google Patents

1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions

Info

Publication number
PH23436A
PH23436A PH29057A PH29057A PH23436A PH 23436 A PH23436 A PH 23436A PH 29057 A PH29057 A PH 29057A PH 29057 A PH29057 A PH 29057A PH 23436 A PH23436 A PH 23436A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
optically active
dihydropyridine derivatives
racemate form
racemate
Prior art date
Application number
PH29057A
Other languages
English (en)
Inventor
Arnold Vogel
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH23436A publication Critical patent/PH23436A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PH29057A 1982-06-15 1983-06-14 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions PH23436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15

Publications (1)

Publication Number Publication Date
PH23436A true PH23436A (en) 1989-08-07

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29057A PH23436A (en) 1982-06-15 1983-06-14 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions

Country Status (19)

Country Link
AU (1) AU1575383A (es)
BE (1) BE897000A (es)
CA (1) CA1208639A (es)
CH (1) CH660593A5 (es)
DE (1) DE3320616A1 (es)
DK (1) DK271183A (es)
ES (2) ES8504179A1 (es)
FI (1) FI832072L (es)
FR (1) FR2528431B1 (es)
GB (1) GB2122192B (es)
HU (1) HU191853B (es)
IT (1) IT1178353B (es)
NL (1) NL8302067A (es)
NZ (1) NZ204536A (es)
PH (1) PH23436A (es)
PT (1) PT76870B (es)
SE (1) SE8303385L (es)
WO (1) WO1984000033A1 (es)
ZA (1) ZA834409B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
DE3809912A1 (de) * 1987-03-27 1988-10-27 Byk Gulden Lomberg Chem Fab Neue zwischenprodukte zur herstellung von 1,4-dihydropyridin-3,5-dicarbonsaeurederivaten
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
CH660593A5 (de) 1987-05-15
FR2528431A1 (fr) 1983-12-16
ZA834409B (en) 1985-02-27
WO1984000033A1 (en) 1984-01-05
NZ204536A (en) 1986-09-10
GB2122192B (en) 1985-12-18
AU1575383A (en) 1983-12-22
SE8303385L (sv) 1983-12-16
HU191853B (en) 1987-04-28
DK271183A (da) 1983-12-16
ES8604578A1 (es) 1986-02-01
IT8348488A0 (it) 1983-06-13
ES538157A0 (es) 1986-02-01
FI832072A0 (fi) 1983-06-08
PT76870B (en) 1986-02-27
CA1208639A (en) 1986-07-29
ES523243A0 (es) 1985-04-01
FR2528431B1 (fr) 1986-01-10
SE8303385D0 (sv) 1983-06-14
PT76870A (en) 1983-07-01
NL8302067A (nl) 1984-01-02
GB2122192A (en) 1984-01-11
IT1178353B (it) 1987-09-09
FI832072L (fi) 1983-12-16
DE3320616A1 (de) 1983-12-15
GB8316054D0 (en) 1983-07-20
BE897000A (fr) 1983-12-09
ES8504179A1 (es) 1985-04-01
DK271183D0 (da) 1983-06-13

Similar Documents

Publication Publication Date Title
NZ212895A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IL60937A (en) Optically active 1,4-dihydropyridine compounds,their production and pharmaceutical compositions containing them
DE3265978D1 (en) 1,4-dihydropyridine derivative and pharmaceutical composition containing same
EP0161877A3 (en) 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same
IL73706A0 (en) 2,2'-iminobisethanol derivatives,their preparation and pharmaceutical compositions containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
NZ222030A (en) Substituted imidazo-(5,4-g (3,1 benzoxaminone derivatives and pharmaceutical compositions
IL71187A0 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
PH23436A (en) 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions
IL72152A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL68970A0 (en) Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ218087A (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions
IL85254A0 (en) 14,15-substituted lanosterols and pharmaceutical compositions containing them
IL89377A0 (en) Substituted imidazolinones and imidazolinethiones,their preparation and pharmaceutical compositions containing them